Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review
The Journal of Clinical Endocrinology & Metabolism · 15.10.2024 · 109 (11) · e2141-e2150
DOI: 10.1210/clinem/dgae023 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 10.01.2024. Verfasst von Douglas C Bauer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA. Hauptthemen laut MEDLINE: Diphosphonates, Femoral Fractures, Bone Density Conservation Agents. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Context
Prolonged bisphosphonate (BP) treatment for osteoporosis prevents hip and other fractures but causes atypical femoral fractures (AFF).
Objective
To establish the relationship between patterns of BP use and the risk of AFF and hip fractures. Other potential risk factors for AFF were also examined.
Methods
This population-based case-cohort study utilized data from the Danish National Healthcare system, including longitudinal records of medication use, healthcare utilization, and x-ray images. Among all 1.9 million Danish adults ≥50, those with subtrochanteric or femoral shaft fractures between 2010 and 2015 (n = 4973) were identified and compared to a random sample (n = 37 021). Bisphosphonate use was collected from 1995-2015. Fracture radiographs (n = 4769) were reviewed by blinded study radiologists to identify AFFs (n = 189) using established criteria. Traditional hip fractures in the random sample (n = 691) were identified by ICD-10.
Results
Compared to <1 year of BP use, 5 to 7 years of use was associated with a 7-fold increase in AFF (adjusted HR = 7.29 [CI: 3.07, 17.30]); the risk of AFF fell quickly after discontinuation. The 5-year number needed to harm for one AFF was 1424, while the 5-year number needed to treat to prevent one hip fracture was 56. Glucocorticoid and proton pump inhibitor use were independently associated with increased AFF risk. Thirty-one percent of those with AFF had no BP exposure.
Conclusion
The risk of AFF increases with duration of BP use but the beneficial effects of BP therapy in adults ≥50 dramatically exceed this increased risk. Nearly one-third of those with AFF have no BP exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
- Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94143, USA.
- Kaiser Permanente Southern California, Downey, CA 90242, USA.
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94143, USA.
- Rockwool Foundation, Copenhagen 1472, Denmark.
- Department of Public Health, University of Southern Denmark, Odense 5000, Denmark.
ORCID-Profile: Douglas C Bauer, Eric Vittinghoff
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Bauer, D. C., Black, D. M., Dell, R., Fan, B., Smith, C. D., Ernst, M. T., Jurik, A. G., Frøkjær, J. B., Boesen, M., Vittinghoff, E., & Abrahamsen, B. (2024). Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review. The Journal of Clinical Endocrinology & Metabolism, 109(11), e2141-e2150. https://doi.org/10.1210/clinem/dgae023
Vancouver
Bauer DC, Black DM, Dell R, Fan B, Smith CD, Ernst MT, et al. Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review. The Journal of Clinical Endocrinology & Metabolism. 2024;109(11):e2141-e2150. doi:10.1210/clinem/dgae023
BibTeX
@article{Bauer2024,
author = {Bauer, Douglas C and Black, Dennis M and Dell, Rick and Fan, Bo and Smith, Christopher D and Ernst, Martin T and Jurik, Anne G and Frøkjær, Jens B and Boesen, Mikael and Vittinghoff, Eric and Abrahamsen, Bo},
title = {Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {11},
pages = {e2141--e2150},
doi = {10.1210/clinem/dgae023}
}
EUVIMED